<unk>  is at least partially metabolized by the cytochrome P450 enzymes CYP2C8, CYP2D6, and CYP3A4. Blood plasma concentrations of<unk>  are expected to decrease if it is administered together with cytochrome P450 inducers such as rifampicin, carbamazepine, phenobarbital, phenytoin, primidone, and St John's wort. Using chloroquine or hydroxychloroquine with<unk>  may reduce the antiviral activity of<unk> . Coadministration of<unk>  and chloroquine phosphate or hydroxychloroquine sulfate is not recommended based on in vitro data demonstrating an antagonistic effect of chloroquine on the intracellular metabolic activation and antiviral activity of<unk> .
Remdesivir
Coronavir
Entecavir
Saquinavir
Letermovir
Odalasvir
Maribavir
Fostemsavir